Notice: This company has been marked as potentially delisted and may not be actively trading. Reliv' International (RELV) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends RELV vs. BCTX, PULM, LSTA, GOVX, NNVC, IBIO, BFRG, COCP, BOLT, and TENXShould you be buying Reliv' International stock or one of its competitors? The main competitors of Reliv' International include BriaCell Therapeutics (BCTX), Pulmatrix (PULM), Lisata Therapeutics (LSTA), GeoVax Labs (GOVX), NanoViricides (NNVC), iBio (IBIO), Bullfrog AI (BFRG), Cocrystal Pharma (COCP), Bolt Biotherapeutics (BOLT), and Tenax Therapeutics (TENX). Reliv' International vs. BriaCell Therapeutics Pulmatrix Lisata Therapeutics GeoVax Labs NanoViricides iBio Bullfrog AI Cocrystal Pharma Bolt Biotherapeutics Tenax Therapeutics Reliv' International (NASDAQ:RELV) and BriaCell Therapeutics (NASDAQ:BCTX) are both small-cap consumer staples companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, media sentiment, institutional ownership, risk, community ranking and analyst recommendations. Which has stronger earnings & valuation, RELV or BCTX? Reliv' International has higher revenue and earnings than BriaCell Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioReliv' International$35.06M0.16-$440KN/AN/ABriaCell TherapeuticsN/AN/A-$4.79M-$0.89-0.63 Is RELV or BCTX more profitable? BriaCell Therapeutics has a net margin of 0.00% compared to Reliv' International's net margin of -0.61%. BriaCell Therapeutics' return on equity of 0.00% beat Reliv' International's return on equity.Company Net Margins Return on Equity Return on Assets Reliv' International-0.61% -1.89% -1.31% BriaCell Therapeutics N/A N/A -44.65% Does the MarketBeat Community believe in RELV or BCTX? Reliv' International received 93 more outperform votes than BriaCell Therapeutics when rated by MarketBeat users. However, 100.00% of users gave BriaCell Therapeutics an outperform vote while only 70.27% of users gave Reliv' International an outperform vote. CompanyUnderperformOutperformReliv' InternationalOutperform Votes10470.27% Underperform Votes4429.73% BriaCell TherapeuticsOutperform Votes11100.00% Underperform VotesNo Votes Does the media refer more to RELV or BCTX? In the previous week, BriaCell Therapeutics had 4 more articles in the media than Reliv' International. MarketBeat recorded 4 mentions for BriaCell Therapeutics and 0 mentions for Reliv' International. Reliv' International's average media sentiment score of 0.00 beat BriaCell Therapeutics' score of -0.60 indicating that Reliv' International is being referred to more favorably in the media. Company Overall Sentiment Reliv' International Neutral BriaCell Therapeutics Negative Do analysts recommend RELV or BCTX? BriaCell Therapeutics has a consensus target price of $15.00, suggesting a potential upside of 2,573.80%. Given BriaCell Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe BriaCell Therapeutics is more favorable than Reliv' International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Reliv' International 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00BriaCell Therapeutics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders & institutionals have more ownership in RELV or BCTX? 8.0% of Reliv' International shares are held by institutional investors. Comparatively, 15.4% of BriaCell Therapeutics shares are held by institutional investors. 31.2% of Reliv' International shares are held by company insiders. Comparatively, 21.8% of BriaCell Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has more risk and volatility, RELV or BCTX? Reliv' International has a beta of -0.1, suggesting that its stock price is 110% less volatile than the S&P 500. Comparatively, BriaCell Therapeutics has a beta of 1.46, suggesting that its stock price is 46% more volatile than the S&P 500. SummaryBriaCell Therapeutics beats Reliv' International on 10 of the 16 factors compared between the two stocks. Ad Behind the MarketsWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.Click here for the ticker >>> Get Reliv' International News Delivered to You Automatically Sign up to receive the latest news and ratings for RELV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RELV vs. The Competition Export to ExcelMetricReliv' InternationalPharmaceutical Preparations IndustryStaples SectorNASDAQ ExchangeMarket Cap$5.67M$6.57B$14.04B$9.08BDividend YieldN/A2.99%2.80%4.23%P/E Ratio-29.5410.5921.9717.18Price / Sales0.16196.062.67117.05Price / Cash44.5357.1621.1437.85Price / Book0.515.095.854.78Net Income-$440,000.00$151.83M$572.90M$225.60M Reliv' International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RELVReliv' InternationalN/A$3.25flatN/AN/A$5.67M$35.06M-29.5491BCTXBriaCell Therapeutics2.4489 of 5 stars$0.62-5.7%$15.00+2,309.3%-86.0%$22.53MN/A-0.5616Earnings ReportGap UpPULMPulmatrix0.1943 of 5 stars$6.08+5.7%N/A+198.5%$22.19M$7.30M-2.1820Analyst ForecastNews CoverageLSTALisata Therapeutics1.9047 of 5 stars$2.61+1.2%$15.00+474.7%-4.9%$21.91MN/A-1.1030GOVXGeoVax Labs2.9322 of 5 stars$2.28-3.0%$14.20+522.8%-55.9%$21.51M$3.09M0.0017Analyst ForecastNews CoverageNNVCNanoViricidesN/A$1.50+1.4%N/A+40.6%$20.92MN/A-1.9520IBIOiBio0.988 of 5 stars$2.28-1.3%$4.30+88.6%N/A$20.86M$175,000.000.00100BFRGBullfrog AI0.7303 of 5 stars$2.36+6.3%N/A-24.8%$20.56M$60,000.00-2.864News CoverageCOCPCocrystal Pharma2.6583 of 5 stars$2.00+4.8%$7.00+250.0%+19.0%$20.35MN/A-1.1210Positive NewsBOLTBolt Biotherapeutics2.4659 of 5 stars$0.51-2.6%$3.50+580.9%-49.8%$19.67M$7.88M-0.31100TENXTenax Therapeutics1.4549 of 5 stars$5.76-2.0%$16.00+177.8%-76.7%$19.64MN/A0.009News Coverage Related Companies and Tools Related Companies BCTX Competitors PULM Competitors LSTA Competitors GOVX Competitors NNVC Competitors IBIO Competitors BFRG Competitors COCP Competitors BOLT Competitors TENX Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:RELV) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Reliv' International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Reliv' International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RELV Stock Alerts